Healthcare

Metropolis Healthcare Reports 26% Revenue Growth in Q3; Board Approves 3:1 Bonus Issue

● Feb 5, 2026

India’s second-largest diagnostic chain saw net profit surge 63% on an adjusted basis as specialty testing and acquisition integrations drove...

Inventurus Knowledge Q3 FY26 Earnings Results

● Feb 5, 2026

Executive Summary Inventurus Knowledge Solutions Ltd reported Q3FY26 revenues of ₹815 crore, up 24.05% YoY, with consolidated net profit increasing...

Rubicon Research Reports 52% Revenue Growth in Q3 FY26; Profit Nearly Doubles

● Feb 3, 2026

Rubicon Research Limited (NSE: RUBICON) shares were trading higher following the release of its Q3 FY26 earnings, though stock price...

Aster DM Healthcare Q3 Revenue Rises 13% as Company Advances QCIL Merger Integration

● Feb 2, 2026

Aster DM Healthcare Limited (NSE: ASTERDM) the healthcare provider reported consolidated revenue of ₹1,185.76 crore for the quarter ended December...

Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth

● Feb 2, 2026

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a...

Glenmark Rallies as Q3 Margins Expand, FDA Clears U.S. Facility

● Feb 2, 2026

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) The Mumbai-based pharmaceutical company posts strong domestic and international sales as it transitions toward an...

Rainbow Children’s Medicare’s Q3 FY26 Results Reflect Capacity Expansion and Operational Transition

● Jan 29, 2026

In its Q3 FY2026 financial results, Rainbow Children’s Medicare Ltd (NSE: RAINBOW) delivered a measured performance that reflected both steady...

Piramal Pharma Ltd Q3 FY 2026 Financial Results: Navigating Cyclical Headwinds with Strategic Adjustments

● Jan 29, 2026

Piramal Pharma Ltd (NSE: PPLPHARMA), a leading global pharmaceutical and life sciences company headquartered in Mumbai, reported its financial results...

Thyrocare posts strong Q3 profit growth on higher diagnostic volumes

● Jan 28, 2026

Thyrocare Technologies Ltd. (THYROCARE.NS) on Wednesday reported higher revenue and profit for the third quarter of fiscal 2026, supported by...

Vimta Labs Q3 Revenue Rises 10%, Profit Flat Amid Margin Pressure

● Jan 28, 2026

Vimta Labs Ltd. (NSE: VIMTALABS) on Wednesday reported a modest rise in quarterly revenue for the three months ended Dec....